Pasithea Therapeutics - Warrants (11/08/2026) Overview
Pasithea Therapeutics - Warrants (11/08/2026) Discounted Cash Flow
DCF Analysis for KTTAW.
Get informed when a big investor buys or sells
+ FollowFair Value
$13.25
Current Fair Value
$13.25
↑ 228305.2% Upside
Undervalued by 228305.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison